Patenting Parthenotes

Against the backdrop of an increasingly unfavourable European legal landscape for human stem cell patents (see LSIPR 2014, 1.3), in his recent opinion in case C-364/13 the Advocate General (AG) Pedro Cruz Villalón of the Court of Justice of the European Union (CJEU) gives reason to believe that there is some light on the horizon for applicants seeking patent protection for stem cell-related inventions.